U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
RELEASE DATE
13-May-2008
13-May-2008
REGION
North America
North America
Research Code: N167-01-00-00-00
SKU: HC02031-NA-MR_07346
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02031-NA-MR_07346
Description
This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope & Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Technology Overview
- Disease Overviews - Oncology
- Disease Overviews - Autoimmune and Inflammatory Disorders
- Disease Overviews - Organ Transplantation
- Disease Overviews - Cardiovascular Disorders
- Disease Overview - Infectious Diseases
- Disease Overviews - Other Diseases
- Industry Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Oncology
- Autoimmune and Inflammatory Disorders
- Organ Transplantation
- Cardiovascular Disorders
- Infectious Diseases
- Other Indications
Pipeline Analysis
- Oncology
- Autoimmune and Inflammatory Disorders
- Organ Transplantation
- Cardiovascular Disorders
- Infectious Diseases
- Other Indications
- Additional Indications for Marketed Products
Competitive Analysis
Forecasts and Trends
Market Share Analysis
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplant Databases
Cardiovascular Databases
Other Indications Databases
Popular Topics
This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N167-01-00-00-00 |
Is Prebook | No |